Table 8. Annotations Enriched at Corrected Significance Levels among Dysregulated Transcripts across Studies Comparing PTSD Cases and Comparison Subjects.

DAVID Category	Term	Count (%)	Fold- Enrichment	p	Bonferroni- Corrected p	Gene Corresponding to Dysregulated Exon
GOTERM_BP_FAT	GO:0001775∼cell activation	15 (8.1%)	5.1	1.2E-06	2.1E-03	BLM, SWAP70, STAT5B, KLRK1, MINK1, PF4, IGF2, SLAMF1, TGFB1, AZU1, CCND3, C14ORF19, TREML1, F2R, CD7
GOTERM_BP_FAT	GO:0009611∼response to wounding	19 (10.2%)	3.5	6.6E-06	1.1E-02	LIPA, CCR1, STAT5B, CXCR1, PF4, IGF2, SOD1, CCL5, DTNBP1, TGFB1, GP9, AZU1, ORM1, CX3CR1, CTSB, PLA2G4C, TREML1, KDM6B, F2R
GOTERM_CC_FAT	GO:0030141∼secretory granule	10 (5.4%)	5.7	5.9E-05	1.3E-02	AZU1, SPAG8, PPBP, CPA3, PF4, SPARC, TREML1, RACGAP1, TGFB1, GP9
GOTERM_BP_FAT	GO:0001817∼regulation of cytokine production	11 (5.9%)	6.0	1.5E-05	2.5E-02	AZU1, IL18, TIA1, STAT5B, KLRK1, IGF2, PF4, TRIM16, SOD1, TGFB1, F2R
GOTERM_CC_FAT	GO:0031091∼platelet alpha granule	6 (3.2%)	11.0	2.0E-04	4.1E-02	PPBP, PF4, SPARC, TREML1, TGFB1, GP9
GOTERM_CC_FAT	GO:0000323∼lytic vacuole	10 (5.4%)	4.9	2.0E-04	4.2E-02	AZU1, LAPTM5, LIPA, MMD, IFI30, CPA3, CTSC, CTSB, ASAH1, GBA
GOTERM_CC_FAT	GO:0005764∼lysosome	10 (5.4%)	4.9	2.0E-04	4.2E-02	AZU1, LAPTM5, LIPA, MMD, IFI30, CPA3, CTSC, CTSB, ASAH1, GBA
KEGG_PATHWAY	hsa04060:cytokine-cytokine receptor interaction	13 (7.0%)	3.2	5.0E-04	4.5E-02	TNFRSF21, IL18R1, IL18, CCR1, CXCR1, PF4, CCL5, TGFB1, PPBP, CX3CR1, CSF2RB, IL2RG, IL3RA
GOTERM_MF_FAT	GO:0019955∼cytokine binding	8 (4.3%)	7.0	1.4E-04	4.9E-02	IL18R1, CCR1, CX3CR1, CSF2RB, CXCR1, IL2RG, TRIM16, IL3RA
Reactome	Term	Count (%)		p	FDR-corrected p	Gene Corresponding to Dysregulated Exon
	Cytokine-cytokine receptor interaction	13 (7.0%)		1.0E-05	3.0E-03	IL18,TGFB1,PPBP,CX3CR1,CCL5,IL3RA,CXCR1,CSF2RB,TNFRSF21, CCR1,PF4,IL2RG,IL18R1
	Lysosome	7 (3.8%)		3.0E-04	3.5E-02	NAPSA,LAPTM5,ASAH1,CTSC,CTSB,GBA,LIPA
	Interleukin signaling pathway	5 (2.7%)		3.0E-04	4.7E-02	IL16,IL18,STAT5B,IL3RA,CXCR1